Healgen is a biomedical diagnostic company providing high quality, reliable, and safe medical diagnostic products for professional and point-of-care settings.
Founded in 2010 in Houston, Texas.
Expanded its portfolio from rapid diagnostic toxicology test kits to include infectious disease tests.
In 2020, introduced rapid antigen and antibody testing products for COVID-19.
Currently has distribution in over 100 countries worldwide.
Abbott Laboratories is a global healthcare company producing a wide range of diagnostic devices, medical devices, and pharmaceuticals.
Roche Diagnostics is a global diagnostics company focused on developing and producing innovative medical tests and diagnostic tools.
BD Diagnostics is a medical technology company dedicated to improving the discovery, diagnosis, and treatment of infectious diseases.
A rapid diagnostic test used to detect the presence of SARS-CoV-2 antigens in nasal swab specimens.
A rapid diagnostic test used to detect the presence of IgG and IgM antibodies against SARS-CoV-2 in blood samples.
A line of rapid diagnostic tests used to detect the presence of drugs and drug metabolites in urine, oral fluid, and saliva samples.
Healgen's COVID-19 rapid antigen test has a sensitivity of 89.7% and a specificity of 99.5%.
Yes, Healgen's COVID-19 rapid antigen test can be used for asymptomatic individuals.
Healgen's COVID-19 rapid antigen test provides results in 15 minutes.
Yes, Healgen's COVID-19 rapid antigen test is FDA approved.
A positive IgG or IgM result means the patient has been infected with SARS-CoV-2 at some point in the past. A negative result does not rule out COVID-19 infection and should be confirmed by a molecular test if necessary.